Background: Owing to the high prevalence and detrimental consequences, postpartum
depression (PPD) has been identified as one of the severe global public health issues in the …

Postpartum depression (PPD) is common, disabling, and treatable. The strongest risk factor
is a history of mood or anxiety disorder, especially having active symptoms during …

Pregnancy is a complex and vulnerable period that presents a number of challenges to
women, including the development of postpartum psychiatric disorders (PPDs). These …

Background: The COVID-19 pandemic has resulted in an unprecedented situation for new
parents, with public health orders greatly affecting daily life as well as various aspects of …

Background Despite the increased global interest from researchers in postpartum
depression (PPD) and postpartum post-traumatic stress disorder (PP-PTSD), studies of PPD …

Antenatal and postpartum depression are very common and have significant consequences
for mothers and their children. This review examines which antenatal depression (AD) and …

Introduction: Effective social support can have a critical influence on a mother's ability to
initiate and continue breastfeeding. Coronavirus disease (COVID-19) has created …

Objective: There is a scarcity in tools to predict postpartum depression (PPD). We propose a
machine learning framework for PPD risk prediction using data extracted from electronic …

The extraordinary health emergency of the COVID-19 pandemic represents a new challenge
for mental health researchers and clinical practitioners. The related containment measures …

The recent FDA approval of the neurosteroid, brexanolone (allopregnanolone), as a
treatment for women with postpartum depression, and successful trials of a related …